Anipryl 2 mg, 30 Tablets is the first FDA-approved monoamine oxidase inhibitor (MAOI) used to treat Canine Cognitive Dysfunction Syndrome. Anipryl (selegiline) also treats the symptoms associated with pituitary-dependent canine Cushing's Disease. Many dogs show results in as little as one month when treated for age-related cognitive dysfunction.
- Treats Canine Cognitive Dysfunction Syndrome, or senility
- Treats pituitary tumor-related Cushing's Disease in dogs
- Results in little as one month
- Manufacturer information and usage